◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2453

Concord Healthcare Group Co., Ltd. (2453) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Care Facilities · DATA UPDATED 2026-08-11

Concord Healthcare Group Co., Ltd. (2453) operates in the Medical Care Facilities industry and is headquartered in Beijing, China with about 592 employees. Its market capitalization is roughly CNY 639 million. In the fiscal year ended 2025-12-31, 2453 reported CNY 460M in revenue and (CNY 257M) in net income.

Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People's Republic of China. It operates through Hospital Business; and Medical Equipment, Software and Related Services segments.

Interactive charts & full statements →

2453 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 460MCNY 388MCNY 539MCNY 472M
Gross ProfitCNY 32M(CNY 67M)(CNY 65M)(CNY 143M)
Operating Income (EBIT)(CNY 218M)(CNY 421M)(CNY 354M)(CNY 456M)
Net Income(CNY 257M)(CNY 443M)(CNY 373M)(CNY 541M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2453 Free Cash Flow History

2453 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 5.8BCNY 5.9BCNY 5.2BCNY 5.4B
Total LiabilitiesCNY 3.8BCNY 4.0BCNY 3.4BCNY 3.4B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2453 viewer.

Other Companies in Medical Care Facilities

← 2451All “0-9” companies2454 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.